{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-21-026622","form_type":"8-K","ticker":"PURE","cik":"0001006028","company_name":"PURE BIOSCIENCE, INC.","filed_at":"2021-10-28T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.039499+00:00","generated_at":"2026-06-28T16:28:23.797335+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"PURE Bioscience reports FY2021 net loss of $2.3M; product sales drop 47% YoY","bullets":["Net product sales $3.698M, down 47% from $6.917M in FY2020.","Net loss of $2.3M vs net income of $4K in prior year; diluted loss per share $(0.03).","Gross margin fell to 50% from 58% due to product mix shift.","Cash used in operations $1.2M vs cash provided $669K in prior year.","Business updates: ongoing work with Taylor Farms, new adoption by citrus packer and indoor farming firm, new sales hire."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-21-026622","json":"https://secwatch.observer/filing/0001493152-21-026622.json","markdown":"https://secwatch.observer/filing/0001493152-21-026622.md","text":"https://secwatch.observer/filing/0001493152-21-026622.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1006028/000149315221026622/0001493152-21-026622-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1006028/000149315221026622/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T16:28:23.797335+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}